Mike Khouw joins 'Fast Money' to talk the options trade around Hims. Federal judge blocks largest supermarket merger in ...

Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these ...

Eli Lily continues to dominate the weight loss market, willing to crush any competitor that threatens its dominance. One such ...

The partnership between Ro and Eli Lilly (LLY) to streamline access to Lilly’s GLP-1 Zepbound single-dose vials for Ro patients with obesity is ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.87 which represents a decrease of $-1.76 or -5.39% from the prior close of $32.63. The stock opened at $32.25 and touched a low ...

BofA analyst Allen Lutz notes Ro Health, a direct competitor to Hims & Hers (HIMS), announced that the company is working with Eli Lilly ...

Hims & Hers can beat Amazon in the telehealth market thanks to its unique advantages. Find out why HIMS stock is a Buy.

Hims & Hers Health is financially strong with minimal debt and a dominant market share. Find out what makes HIMS stock a ...

The digital health industry has experienced impressive growth, driven by rising healthcare demands, digitalization, and ...

Cola, Hims & Hers, McDonald’s, e.l.f., and Liquid Death were behind some of the buzziest product launches of the year.

Investors in Hims & Hers Health Inc (Symbol: HIMS) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 4.15% over the last five trades and 53.10% over the past 30 trades. This represents a notable shift ...